These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 28685644)

  • 21. Quality of Evidence Underlying the American Heart Association/American College of Cardiology/Heart Rhythm Society Guidelines on the Management of Atrial Fibrillation.
    Barnett AS; Lewis WR; Field ME; Fonarow GC; Gersh BJ; Page RL; Calkins H; Steinberg BA; Peterson ED; Piccini JP
    JAMA Cardiol; 2017 Mar; 2(3):319-323. PubMed ID: 28002833
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Improved outcomes with European Society of Cardiology guideline-adherent antithrombotic treatment in high-risk patients with atrial fibrillation: a report from the EORP-AF General Pilot Registry.
    Lip GY; Laroche C; Popescu MI; Rasmussen LH; Vitali-Serdoz L; Dan GA; Kalarus Z; Crijns HJ; Oliveira MM; Tavazzi L; Maggioni AP; Boriani G
    Europace; 2015 Dec; 17(12):1777-86. PubMed ID: 26321406
    [TBL] [Abstract][Full Text] [Related]  

  • 23. ESC Congress 2020, the digital experience: a report from the ESC Scientists of Tomorrow.
    Schmidt C; Bollini S
    Cardiovasc Res; 2020 Nov; 116(13):e190-e192. PubMed ID: 33096565
    [No Abstract]   [Full Text] [Related]  

  • 24. Thromboembolism and antithrombotic therapy for heart failure in sinus rhythm: an executive summary of a joint consensus document from the ESC Heart Failure Association and the ESC Working Group on Thrombosis.
    Lip GY; Piotrponikowski P; Andreotti F; Anker SD; Filippatos G; Homma S; Morais J; Pullicino P; Rasmussen LH; Marín F; Lane DA;
    Thromb Haemost; 2012 Dec; 108(6):1009-22. PubMed ID: 23093044
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antithrombotic Therapy in Atrial Fibrillation Associated with Valvular Heart Disease: Executive Summary of a Joint Consensus Document from the European Heart Rhythm Association (EHRA) and European Society of Cardiology Working Group on Thrombosis, Endorsed by the ESC Working Group on Valvular Heart Disease, Cardiac Arrhythmia Society of Southern Africa (CASSA), Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), South African Heart (SA Heart) Association and Sociedad Latinoamericana de Estimulación Cardíaca y Electrofisiología (SOLEACE).
    Lip GYH; Collet JP; de Caterina R; Fauchier L; Lane DA; Larsen TB; Marin F; Morais J; Narasimhan C; Olshansky B; Pierard L; Potpara T; Sarrafzadegan N; Sliwa K; Varela G; Vilahur G; Weiss T; Boriani G; Rocca B
    Thromb Haemost; 2017 Dec; 117(12):2215-2236. PubMed ID: 29212110
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Guidelines for the management of dyslipidemia].
    Díaz Rodríguez Á;
    Semergen; 2014 Sep; 40 Suppl 4():19-25. PubMed ID: 25595349
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CAC Score Improves Coronary and CV Risk Assessment Above Statin Indication by ESC and AHA/ACC Primary Prevention Guidelines.
    Mahabadi AA; Möhlenkamp S; Lehmann N; Kälsch H; Dykun I; Pundt N; Moebus S; Jöckel KH; Erbel R;
    JACC Cardiovasc Imaging; 2017 Feb; 10(2):143-153. PubMed ID: 27665163
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [ESC Guidelines 2016 - Heart Failure].
    Adrian L; Werner C; Laufs U
    Dtsch Med Wochenschr; 2017 Aug; 142(15):1123-1127. PubMed ID: 28763821
    [No Abstract]   [Full Text] [Related]  

  • 29. [Current pharmacological management of atrial fibrillation management by practice cardiologists - news from congress in Munich].
    Kułakowski P
    Kardiol Pol; 2008 Sep; 66(9):1026-7. PubMed ID: 19004121
    [No Abstract]   [Full Text] [Related]  

  • 30. Atrial fibrillation patients categorized as "not for anticoagulation" according to the 2014 Canadian Cardiovascular Society algorithm are not "low risk".
    Lip GY; Nielsen PB; Skjøth F; Rasmussen LH; Larsen TB
    Can J Cardiol; 2015 Jan; 31(1):24-8. PubMed ID: 25547546
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Management of patients with atrial fibrillation (compilation of 2006 ACCF/AHA/ESC and 2011 ACCF/AHA/HRS recommendations): a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.
    Anderson JL; Halperin JL; Albert NM; Bozkurt B; Brindis RG; Curtis LH; DeMets D; Guyton RA; Hochman JS; Kovacs RJ; Ohman EM; Pressler SJ; Sellke FW; Shen WK; Wann LS; Curtis AB; Ellenbogen KA; Estes NA; Ezekowitz MD; Jackman WM; January CT; Lowe JE; Page RL; Slotwiner DJ; Stevenson WG; Tracy CM; Fuster V; Rydén LE; Cannom DS; Crijns HJ; Curtis AB; Ellenbogen KA; Le Heuzey JY; Kay GN; Olsson SB; Prystowsky EN; Tamargo JL; Wann S
    J Am Coll Cardiol; 2013 May; 61(18):1935-44. PubMed ID: 23558044
    [No Abstract]   [Full Text] [Related]  

  • 32. Expert panel on cost analysis of atrial fibrillation.
    Fak AS; Küçükoğlu MS; Fak NA; Demir M; Ağir AA; Demirtaş M; Köse S; Özdemir M
    Anadolu Kardiyol Derg; 2013 Feb; 13(1):26-38. PubMed ID: 23070633
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Regional differences in presentation and treatment of patients with atrial fibrillation in Europe: a report from the EURObservational Research Programme Atrial Fibrillation (EORP-AF) Pilot General Registry.
    Lip GY; Laroche C; Boriani G; Dan GA; Santini M; Kalarus Z; Rasmussen LH; Oliveira MM; Mairesse G; Crijns HJ; Simantirakis E; Atar D; Maggioni AP; Tavazzi L
    Europace; 2015 Feb; 17(2):194-206. PubMed ID: 25149078
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Case studies with the experts: management decisions in atrial fibrillation.
    Prystowsky EN; Jaïs P; Kowey P; Nattel S; Ruskin JN
    J Cardiovasc Electrophysiol; 2008 Feb; 19 Suppl 1():S1-12; quiz S13-5. PubMed ID: 18226097
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparing the 2010 North American and European atrial fibrillation guidelines.
    Gillis AM; Skanes AC
    Can J Cardiol; 2011; 27(1):7-13. PubMed ID: 21329856
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Assessing gaps in cholesterol treatment guidelines for primary prevention of cardiovascular disease based on available randomised clinical trial evidence: The Rotterdam Study.
    Pavlović J; Greenland P; Deckers JW; Kavousi M; Hofman A; Ikram MA; Franco OH; Leening MJ
    Eur J Prev Cardiol; 2018 Mar; 25(4):420-431. PubMed ID: 29171772
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Organization of heart failure management in European Society of Cardiology member countries: survey of the Heart Failure Association of the European Society of Cardiology in collaboration with the Heart Failure National Societies/Working Groups.
    Seferovic PM; Stoerk S; Filippatos G; Mareev V; Kavoliuniene A; Ristic AD; Ponikowski P; McMurray J; Maggioni A; Ruschitzka F; van Veldhuisen DJ; Coats A; Piepoli M; McDonagh T; Riley J; Hoes A; Pieske B; Dobric M; Papp Z; Mebazaa A; Parissis J; Ben Gal T; Vinereanu D; Brito D; Altenberger J; Gatzov P; Milinkovic I; Hradec J; Trochu JN; Amir O; Moura B; Lainscak M; Comin J; Wikström G; Anker S;
    Eur J Heart Fail; 2013 Sep; 15(9):947-59. PubMed ID: 23787723
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Practice implications of the Atrial Fibrillation Guidelines.
    Curtis AB
    Am J Cardiol; 2013 Jun; 111(11):1660-70. PubMed ID: 23507710
    [TBL] [Abstract][Full Text] [Related]  

  • 39. European Society of Cardiology (ESC) Congress Report from Munich 2012.
    Ozaki Y
    Circ J; 2012; 76(11):2530-5. PubMed ID: 23075818
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Upstream therapy of atrial fibrillation.
    Smit MD; Van Gelder IC
    Expert Rev Cardiovasc Ther; 2009 Jul; 7(7):763-78. PubMed ID: 19589113
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.